| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Endocrinology |
AP/HP, Hôpital Européen Georges Pompidou, Département de Génétique Moléculaire [A-P. G-R., C. R., M. C., V. N., P. K. V. K., X. J.]; INSERM U36, Collège de France [A-P. G-R., J. F., P. C., P-F. P., X. J.]; INSERM U393, Hôpital des Enfants Malades [P. R.]; and AP/HP, Hôpital Européen Georges Pompidou, Service dHypertension Artérielle [P. C., P-F. P.], Paris
Germ-line mutations in the genes encoding succinate dehydrogenase complex subunits B (SDHB) and D (SDHD) have been reported in familial paragangliomas and apparently sporadic phaeochromocytomas (ASP), but the genotypephenotype relationships of these mutations are unknown. Eighty-four patients (all but 2 followed up for 8.8 ± 5.7 years) with ASP (57 with adrenal tumors, 27 with extra-adrenal, multiple, malignant, or recurrent tumors) were screened for the major susceptibility genes for phaeochromocytoma (RET, VHL, SDHD, and SDHB). Thirty-three tumors were available for molecular analysis, enzyme assays, and immunohistochemistry. No (0%) RET and 2 (2.4%) VHL mutations were detected. Only two coding single nucleotide polymorphisms in the SDHD gene (G12S and H50R) were found in 6 patients (7%). Conversely, six deleterious mutations in the SDHB gene were identified in 8 patients (9.5%). Ectopic site and recurrence or malignancy were strongly associated with SDHB mutations (7 of 8, 87%, versus 20 of 76, 26%; P = 0.001). Somatic DNA analysis indicated a loss of heterozygosity at chromosome 1p36 (SDHB locus) in 16 of 33 cases (48%). A loss of heterozygosity at the SDHB locus was found in all tumors with SDHB mutation, and assays of respiratory chain enzymes showed a complete loss of complex II catalytic activity. The vascular architecture of tumors with SDHB mutations displayed features typical of malignancy. These data strongly suggest that SDHB gene is a tumor suppressor gene and that the identification of germ-line mutations in SDHB gene in patients with ASPs should be considered as a high-risk factor for malignancy or recurrence.
This article has been cited by other articles:
![]() |
N. Burnichon, V. Rohmer, L. Amar, P. Herman, S. Leboulleux, V. Darrouzet, P. Niccoli, D. Gaillard, G. Chabrier, F. Chabolle, et al. The Succinate Dehydrogenase Genetic Testing in a Large Prospective Series of Patients with Paragangliomas J. Clin. Endocrinol. Metab., August 1, 2009; 94(8): 2817 - 2827. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. J L M Timmers, A.-P. Gimenez-Roqueplo, M. Mannelli, and K. Pacak Clinical aspects of SDHx-related pheochromocytoma and paraganglioma Endocr. Relat. Cancer, June 1, 2009; 16(2): 391 - 400. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Goffrini, T. Ercolino, E. Panizza, V. Giache, L. Cavone, A. Chiarugi, V. Dima, I. Ferrero, and M. Mannelli Functional study in a yeast model of a novel succinate dehydrogenase subunit B gene germline missense mutation (C191Y) diagnosed in a patient affected by a glomus tumor Hum. Mol. Genet., May 15, 2009; 18(10): 1860 - 1868. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Mannelli, M. Castellano, F. Schiavi, S. Filetti, M. Giacche, L. Mori, V. Pignataro, G. Bernini, V. Giache, A. Bacca, et al. Clinically Guided Genetic Screening in a Large Cohort of Italian Patients with Pheochromocytomas and/or Functional or Nonfunctional Paragangliomas J. Clin. Endocrinol. Metab., May 1, 2009; 94(5): 1541 - 1547. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. K Ghayee, B. Havekes, E. P M Corssmit, G. Eisenhofer, S. R Hammes, Z. Ahmad, A. Tessnow, I. Lazurova, K. T Adams, A. T Fojo, et al. Mediastinal paragangliomas: association with mutations in the succinate dehydrogenase genes and aggressive behavior Endocr. Relat. Cancer, March 1, 2009; 16(1): 291 - 299. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Peczkowska, Z. Erlic, M. M. Hoffmann, M. Furmanek, J. Cwikla, A. Kubaszek, A. Prejbisz, Z. Szutkowski, A. Kawecki, K. Chojnowski, et al. Impact of Screening Kindreds for SDHD p.Cys11X as a Common Mutation Associated with Paraganglioma Syndrome Type 1 J. Clin. Endocrinol. Metab., December 1, 2008; 93(12): 4818 - 4825. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. T. Adler, G. Y. Meyer-Rochow, H. Chen, D. E. Benn, B. G. Robinson, R. S. Sippel, and S. B. Sidhu Pheochromocytoma: Current Approaches and Future Directions Oncologist, July 1, 2008; 13(7): 779 - 793. [Abstract] [Full Text] [PDF] |
||||
![]() |
A Cascon, I Landa, E Lopez-Jimenez, A Diez-Hernandez, M Buchta, C Montero-Conde, S Leskela, L J Leandro-Garcia, R Leton, C Rodriguez-Antona, et al. Molecular characterisation of a common SDHB deletion in paraganglioma patients J. Med. Genet., April 1, 2008; 45(4): 233 - 238. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Lima, T. Feijao, A. Ferreira da Silva, I. Pereira-Castro, G. Fernandez-Ballester, V. Maximo, A. Herrero, L. Serrano, M. Sobrinho-Simoes, and G. Garcia-Rostan High Frequency of Germline Succinate Dehydrogenase Mutations in Sporadic Cervical Paragangliomas in Northern Spain: Mitochondrial Succinate Dehydrogenase Structure-Function Relationships and Clinical-Pathological Correlations J. Clin. Endocrinol. Metab., December 1, 2007; 92(12): 4853 - 4864. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Amar, E. Baudin, N. Burnichon, S. Peyrard, S. Silvera, J. Bertherat, X. Bertagna, M. Schlumberger, X. Jeunemaitre, A.-P. Gimenez-Roqueplo, et al. Succinate Dehydrogenase B Gene Mutations Predict Survival in Patients with Malignant Pheochromocytomas or Paragangliomas J. Clin. Endocrinol. Metab., October 1, 2007; 92(10): 3822 - 3828. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. H. van Nederveen, E. Korpershoek, J. W.M. Lenders, R. R. de Krijger, and W. N.M. Dinjens Somatic SDHB Mutation in an Extraadrenal Pheochromocytoma N. Engl. J. Med., July 19, 2007; 357(3): 306 - 308. [Full Text] [PDF] |
||||
![]() |
E. Korpershoek, B.-J. Petri, F. H van Nederveen, W. N M Dinjens, A. A Verhofstad, W. W de Herder, S. Schmid, A. Perren, P. Komminoth, and R. R de Krijger Candidate gene mutation analysis in bilateral adrenal pheochromocytoma and sympathetic paraganglioma Endocr. Relat. Cancer, June 1, 2007; 14(2): 453 - 462. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Scholz, G. Eisenhofer, K. Pacak, H. Dralle, and H. Lehnert Current Treatment of Malignant Pheochromocytoma J. Clin. Endocrinol. Metab., April 1, 2007; 92(4): 1217 - 1225. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. J. L. M. Timmers, A. Kozupa, G. Eisenhofer, M. Raygada, K. T. Adams, D. Solis, J. W. M. Lenders, and K. Pacak Clinical Presentations, Biochemical Phenotypes, and Genotype-Phenotype Correlations in Patients with Succinate Dehydrogenase Subunit B-Associated Pheochromocytomas and Paragangliomas J. Clin. Endocrinol. Metab., March 1, 2007; 92(3): 779 - 786. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. M. Brouwers, G. Eisenhofer, J. J. Tao, J. A. Kant, K. T. Adams, W. M. Linehan, and K. Pacak High Frequency of SDHB Germline Mutations in Patients with Malignant Catecholamine-Producing Paragangliomas: Implications for Genetic Testing J. Clin. Endocrinol. Metab., November 1, 2006; 91(11): 4505 - 4509. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Pollard, M. El-Bahrawy, R. Poulsom, G. Elia, P. Killick, G. Kelly, T. Hunt, R. Jeffery, P. Seedhar, J. Barwell, et al. Expression of HIF-1{alpha}, HIF-2{alpha} (EPAS1), and Their Target Genes in Paraganglioma and Pheochromocytoma with VHL and SDH Mutations J. Clin. Endocrinol. Metab., November 1, 2006; 91(11): 4593 - 4598. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. H. Pham, C. Moir, G. B. Thompson, A. E. Zarroug, C. E. Hamner, D. Farley, J. van Heerden, A. N. Lteif, and W. F. Young Jr Pheochromocytoma and Paraganglioma in Children: A Review of Medical and Surgical Management at a Tertiary Care Center Pediatrics, September 1, 2006; 118(3): 1109 - 1117. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. G. Slane, N. Aykin-Burns, B. J. Smith, A. L. Kalen, P. C. Goswami, F. E. Domann, and D. R. Spitz Mutation of Succinate Dehydrogenase Subunit C Results in Increased O2{middle dot}-, Oxidative Stress, and Genomic Instability. Cancer Res., August 1, 2006; 66(15): 7615 - 7620. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Jimenez, G. Cote, A. Arnold, and R. F. Gagel Should Patients with Apparently Sporadic Pheochromocytomas or Paragangliomas be Screened for Hereditary Syndromes? J. Clin. Endocrinol. Metab., August 1, 2006; 91(8): 2851 - 2858. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. R Woodward and E. R Maher Von Hippel-Lindau disease and endocrine tumour susceptibility. Endocr. Relat. Cancer, June 1, 2006; 13(2): 415 - 425. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. R. Maher Genetics of phaeochromocytoma Br. Med. Bull., June 1, 2006; 79-80(1): 141 - 151. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. F. Young Jr and A. L. Abboud Paraganglioma--all in the family. J. Clin. Endocrinol. Metab., March 1, 2006; 91(3): 790 - 792. [Full Text] [PDF] |
||||
![]() |
D. E. Benn, A.-P. Gimenez-Roqueplo, J. R. Reilly, J. Bertherat, J. Burgess, K. Byth, M. Croxson, P. L. M. Dahia, M. Elston, O. Gimm, et al. Clinical Presentation and Penetrance of Pheochromocytoma/Paraganglioma Syndromes J. Clin. Endocrinol. Metab., March 1, 2006; 91(3): 827 - 836. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Amar, J. Bertherat, E. Baudin, C. Ajzenberg, B. Bressac-de Paillerets, O. Chabre, B. Chamontin, B. Delemer, S. Giraud, A. Murat, et al. Genetic Testing in Pheochromocytoma or Functional Paraganglioma J. Clin. Oncol., December 1, 2005; 23(34): 8812 - 8818. [Abstract] [Full Text] [PDF] |
||||
![]() |
P.J. Pollard, J.J. Briere, N.A. Alam, J. Barwell, E. Barclay, N.C. Wortham, T. Hunt, M. Mitchell, S. Olpin, S.J. Moat, et al. Accumulation of Krebs cycle intermediates and over-expression of HIF1{alpha} in tumours which result from germline FH and SDH mutations Hum. Mol. Genet., August 1, 2005; 14(15): 2231 - 2239. [Abstract] [Full Text] [PDF] |
||||
![]() |
L Simi, R Sestini, P Ferruzzi, M S Gagliano, F Gensini, M Mascalchi, L Guerrini, C Pratesi, P Pinzani, G Nesi, et al. Phenotype variability of neural crest derived tumours in six Italian families segregating the same founder SDHD mutation Q109X J. Med. Genet., August 1, 2005; 42(8): e52 - e52. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Cascon, A. Cebrian, M. Pollan, S. Ruiz-Llorente, C. Montero-Conde, R. Leton, R. Gutierrez, F. Lesueur, R. L. Milne, O. Gonzalez-Albarran, et al. Succinate Dehydrogenase D Variants Do Not Constitute a Risk Factor for Developing C Cell Hyperplasia or Sporadic Medullary Thyroid Carcinoma J. Clin. Endocrinol. Metab., April 1, 2005; 90(4): 2127 - 2130. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Eisenhofer, D. S. Goldstein, P. Sullivan, G. Csako, F. M. Brouwers, E. W. Lai, K. T. Adams, and K. Pacak Biochemical and Clinical Manifestations of Dopamine-Producing Paragangliomas: Utility of Plasma Methoxytyramine J. Clin. Endocrinol. Metab., April 1, 2005; 90(4): 2068 - 2075. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Amar, A. Servais, A.-P. Gimenez-Roqueplo, F. Zinzindohoue, G. Chatellier, and P.-F. Plouin Year of Diagnosis, Features at Presentation, and Risk of Recurrence in Patients with Pheochromocytoma or Secreting Paraganglioma J. Clin. Endocrinol. Metab., April 1, 2005; 90(4): 2110 - 2116. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Eisenhofer, S. R Bornstein, F. M Brouwers, N.-K. V Cheung, P. L Dahia, R. R de Krijger, T. J Giordano, L. A Greene, D. S Goldstein, H. Lehnert, et al. Malignant pheochromocytoma: current status and initiatives for future progress Endocr. Relat. Cancer, September 1, 2004; 11(3): 423 - 436. [Abstract] [Full Text] [PDF] |
||||
![]() |
B E Baysal, J E Willett-Brozick, P A A Filho, E C Lawrence, E N Myers, and R E Ferrell An Alu-mediated partial SDHC deletion causes familial and sporadic paraganglioma J. Med. Genet., September 1, 2004; 41(9): 703 - 709. [Full Text] [PDF] |
||||
![]() |
H. P. H. Neumann, C. Pawlu, M. Peczkowska, B. Bausch, S. R. McWhinney, M. Muresan, M. Buchta, G. Franke, J. Klisch, T. A. Bley, et al. Distinct Clinical Features of Paraganglioma Syndromes Associated With SDHB and SDHD Gene Mutations JAMA, August 25, 2004; 292(8): 943 - 951. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |